The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: Overexpression of the nonsignaling interleukin-13 receptor α

Laboratory Investigation

Volumn 78, Issue 5, 1998, Pages 591-602

  Feng, Ningping ^b,f   Lugli, Serena M ^a   Schnyder, Bruno ^a   Gauchat, Jean François M ^c   Graber, Pierre ^c   Schlagenhauf, Edith ^a   Schnarr, Bernd ^d   Wiederkehr Adam, Michèle ^e   Duschl, Albert ^d   Heim, Markus H ^e   Lutz, Ruedi A ^b   Moser, René ^a,g  

^a Institute of Toxicology Schwerzenbach   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f GeneSense Technologies Inc   (Canada)

^g Inst Biopharmaceutical Res Inc   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DISSOCIATION CONSTANT; FIBROBLAST; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; SYNOVIOCYTE;

EID: 0031805083     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Ahmadzadeh N, Shingu M, and Nobunaga M (1990). The effect of recombinant tumor necrosis factor-alpha on super-oxide and metalloproteinase production by synovial cells and chondrocytes. Clin Exp Rheumatol 8:387-391.
2. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, and Leonard WJ (1996). cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 271:29265-29270.
3. Aversa G, Punnonen J, Cocks BG, Malefyt RD, Vega F, Zurawski SM, Zurawski G, and de Vries JE (1993). An interleukin-4 (IL-4) mutant protein inhibits both IL-4 and IL-13-induced human immunoglobulin-G4 (IgG4) and IgE synthesis and B-cell proliferation: Support for a common component shared by IL-4 and IL-13. J Exp Med 178:2213-2218.
4. Caput D, Laurent P, Kaghad M, Lelias J-M, Lefort S, Vita N, and Ferrara P (1996). Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J Biol Chem 271:16921-16926.
5. Chomczynski P and Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:152-159.
6. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, and Mantovani A (1993). Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4. Science 261:472-475.
7. Dayer JM and Burger D (1994). Interleukin-1, tumor necrosis factor and their specific inhibitors. Eur Cytokine Netw 5:563-571.
8. De Wit H, Hendriks DW, Halie MR, and Vellenga E (1994). Interleukin-4 receptor regulation in human monocytic cells. Blood 84:608-615.
9. Duschl A and Sebald W (1996). Transmembrane and intracellular signalling by interleukin-4: Receptor dimerization and beyond. Eur Cytokine Netw 7:37-49.
10. Fu XY, Schindler C, Improta T, Aebersold R, and Darnell JEJ (1992). The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci U S A 89:7840-7843.
11. Gauchat JF, Gauchat D, De Weck AL, and Stadler BM (1989). Cytokine mRNA levels in antigen-stimulated peripheral blood mononuclear cells. Eur J Immunol 19:1079-1085.
12. Gauchat JF, Schlagenhauf E, Feng N, Moser R, Yamage M, Jeannin P, Alouani S, Elson G, Notarangelo LD, Wells T, Eugster HP, and Bonnefoy JY (1997). A novel 4-kb interleukin-13 receptor α mRNA expressed in human B, T, and endothelial cells encoding an alternate type II interleukin-4/interleukin-13 receptor. Eur J Immunol 27:971-978.
13. Goddard DH (1992). Regulation of synovial cell growth by polypeptide growth factors. DNA Cell Biol 11:259-263.
14. Harigai M, Hara M, Yoshimura T, Leonard EJ, Inoue K, and Kashiwazaki S (1993). Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol 69:83-91.
15. Harris E Jr (1984). Pathogenesis of rheumatoid arthritis. Clin Orthop 182:14-23.
16. Haworth C, Brennan FM, Chantry D, Turner M, Maini RN, and Feldmann M (1991). Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis factor-alpha. Eur J Immunol 21:2575-2579.
17. c chain does not function as a subunit shared by the IL-4 and IL13 receptors: Implication for the structure of the IL-4 receptor. J Immunol 155:9-12.
18. He YW, Adkins B, Furse RK, and Malek TR (1995). Expression and function of the gamma(c) subunit of the IL-2, IL-4, and IL-7 receptors - distinct interaction of gamma(c) in the IL-4 receptor. J Immunol 154:1596-1605.
19. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, and Wilson TA (1996). Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 93:497-501.
20. Hirota K, Akahoshi T, Endo H, Kondo H, and Kashiwazaki S (1992). Production of interleukin 8 by cultured synovial cells in response to interleukin 1 and tumor necrosis factor. Rheumatol Int 12:13-16.
21. Isomaki P, Luukkainen R, Toivanen P, and Punnonen J (1996). The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum 39:1693-1702.
22. Izuhara K, Heike T, Otsuka T, Yamaoka K, Mayumi M, Imamura T, Niho Y, and Harada N (1996). Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J Biol Chem 271:619-622.
23. Keegan AD, Johnston JA, Tortolani PJ, McReynolds LJ, Kinzer C, O'Shea JJ, and Paul WE (1995). Similarities and differences in signal transduction by interleukin 4 and interleukin 13: Analysis of Janus kinase activation. Proc Natl Acad Sci U S A 92:7681-7685.
24. Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai K, and Sugamura K (1993). Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 262:1874-1877.
25. Kotanides H and Reich NC (1993). Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 262:1265-1267.
26. Krane SM and Simon LS (1986). Rheumatoid arthritis: Clinical features and pathogenetic mechanisms. [Review]. Med Clin North Am 70:263-284.
27. Krieg PA and Melton DA (1987). In vitro RNA synthesis with SP6 RNA polymerase. Methods Enzymol 155:397-415.
28. Kriegsmann J, Keyszer GM, Geiler T, Brauer R, Gay RE and Gay S (1995). Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. Lab Invest 72:209-214.
29. Leizer T, Cebon J, Layton JE and Hamilton JA (1990). Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I - Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor. Blood 76:1989-1996.
30. Levy DE, Kessler SD, Pine R and Darnell JEJ (1989). Cytoplasmic activation of SGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev 3:1362-1371.
31. Lin JX, Migone TS, Tsang M, Friedmann M, Weatherbee JA, Zhou L, Yamaguchi A, Bloom ET, Mietz J, John S, and Leonard WJ (1995). The role of shared receptor motifs and common stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331-339.
32. Lugli SM, Feng N, Heim MH, Adam M, Schnyder B, Etter H, Yamage M, Eugster HP, Lutz RA, Zurawski G, and Moser R (1997). Tumor necrosis factor enhances the expression of the interleukin (IL)-4 receptor α-chain on endothelial cells increasing IL-4 or IL-13-induced STAT6 activation. J Biol Chem 272:5487-5494.
33. Matthews DJ, Clark PA, Herbert J, Morgan G, Armitage RJ, Kinnon C, Minty A, Grabstein KH, Caput D, Ferrara P, et al (1995). Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15. Blood 85:38-42.
34. Miloux B, Laurent P, Bonnin O, Lupker J, Caput D, Vita N, and Ferrara P (1997). Cloning of the human IL-13Rα1 chain and reconstitution with the IL-4Rα of a functional IL-4/IL-13 receptor complex. FEBS Lett 401:163-166.
35. Morales-Ducret J, Wayner E, Elices MJ, Alvaro-Gracia JM, Zvaifler NJ, and Firestein GS (1992). Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis: Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol 149:1424-1431.
36. Moser R, Schleiffenbaum B, Groscurth P, and Fehr J (1989). Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 83:444-455.
37. Munson PJ and Rodbard D (1980). LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
38. Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, and Leonard WJ (1993). Interleukin-2 receptor γ chain: A functional component of the interleukin-7 receptor. Science 262:1877-1880.
39. Obiri NI, Debinsky W, Leonard WJ, and Puri RK (1995). Receptor for interleukin 13: Interaction with interleukin 4 by a mechanism that does not involve the common g chain shared by receptors for interleukin 2,4,7,9, and 15. J Biol Chem 270:8797-8804.
40. Obiri NI, Leland P, Murata T, Debinski W, and Puri RK (1997). The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J Immunol 158:756-764.
41. c chain. J Clin Invest 98:604-609.
42. Rothman P, Chen YY, Lutzger S, Li SC, Stewart V, Coffman R, and Alt FW (1990). Structure and expression of germ line immunoglobulin heavy-chain epsilon transcripts: Interleukin-4 plus lipopolysaccharide-directed switching to C epsilon. Mol Cell Biol 10:1672-1679.
43. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedman MC, Miyajima A, Puri RK, Paul WE, and Leonard WJ (1993). Interleukin-2 receptor γ chain: A functional component of the interleukin-4 receptor. Science 262: 1880-1883.
44. Schindler C, Fu XY, Improta T, Aebersold R, and Darnell JEJ (1992). Proteins of transcription factor ISGF-3: One gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc Natl Acad Sci U S A 89:7836-7839.
45. Schnyder B, Lugli S, Feng NP, Etter H, Lutz RA, Ryffel B, Sugamura K, Wunderli-Allenspach H, and Moser R (1996a). Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood 87:4286-4295.
46. Schnyder B, Lugli SM, Schnyder-Candrian S, Eng VM, Moser R, Banchereau J, and Car BD (1996b). Biochemical and morphological characterization of vascular and lymphocytic interleukin-4 receptors. Am J Pathol 149:1369-1379.
47. Seitz M, Loetscher P, Dewald B, Towbin H, and Baggiolini M (1996). Opposite effects of interleukin-13 and interleukin-12 on the release of inflammatory cytokines, cytokine inhibitors and prostaglandin E from synovial fibroblasts and blood mononuclear cells. Eur J Immunol 26:2198-2202.
48. Shimada H, Eguchi K, Ueki Y, Nakashima M, Yamashita I, Kawabe Y, Sakai M, Ida H, Aoyagi T, and Nagataki S (1994). Interleukin 4 increases human synovial cell expression of VCAM-1 and T cell binding. Ann Rheum Dis 53:601-607.
49. Smerz-Bertling C and Duschl A (1995). Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140 kDa subunit of the interleukin 4 receptor. J Biol Chem 270:966-970.
50. Strober S and Holoshitz J (1990). Mechanisms of immune injury in rheumatoid arthritis: Evidence for the involvement of T cells and heat-shock protein. Immunol Rev 118:233-255.
51. Sugiyama E, Taki H, Kuroda A, Mino T, Yamashita N and Kobayashi M (1996). Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I. Ann Rheum Dis 55:375-382.
52. Suzuki H, Sugiyama E, Tunru IS, Yamashita N, Matsuno H, Hamazaki T, and Kobayashi M (1993). Suppressive effect of interleukin-4 (IL-4) on IL-6 production by adherent rheumatoid synovial cells. Clin Immunol Immunopathol 66:67-72.
53. Tony HP, Shen BJ, Reusch P, and Sebald W (1994). Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency. Eur J Biochem 225:659-665.
54. Vita N, Lefort S, Laurent P, Caput D, and Ferrara P (1995). Characterization and comparison of the interleukin- 13 receptor with the interleukin-4 receptor on several cell types. J Biol Chem 270:3512-3517.
55. Wicks IP, Leizer T, Wawryk SO, Novotny JR, Hamilton J, Vitti G, and Boyd AW (1992). The effect of cytokines on the expression of MHC antigens and ICAM-1 by normal and transformed synoviocytes. Autoimmunity 12:13-19.
56. Zhong Z, Wen Z, and Darnell JE (1994). Stat3 and Stat4: Members of the family of signal transducers and activators of transcription. Proc Natl Acad Sci U S A 91:4806-4810.
57. Zurawski SM, Chomarat P, Djossou O, Bidaud C, McKenzie ANJ, Miossec P, Banchereau J, and Zurawski G (1995). The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 270:13869-13878.
58. Zurawski SM, Vega F Jr, Huyghe B, and Zurawski B (1993). Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 12:2663-2670.